Shopping Cart
- Remove All
- Your shopping cart is currently empty
Amubarvimab (BRII-196) is a humanized recombinant antibody targeting the spike protein of SARS-CoV-2, with antiviral activity, used in studies of COVID-19 infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $289 | In Stock | |
5 mg | $753 | In Stock | |
10 mg | $1,180 | In Stock | |
25 mg | $1,780 | In Stock | |
50 mg | $2,380 | In Stock |
Description | Amubarvimab (BRII-196) is a humanized recombinant antibody targeting the spike protein of SARS-CoV-2, with antiviral activity, used in studies of COVID-19 infection. |
In vitro | Amubarvimab is a human IgG1 mAb that binds to a non-competing epitope on the spike protein receptor binding domain (RBD) with a KD of 5.88 nM. [1] |
Alias | BRII-196, BRII196 |
Cas No. | 2509447-07-6 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.